AMSTERDAM, June 28 (Bernama-BUSINESS WIRE) -- Ingenico ePayments, the ecommerce division of Ingenico Group (Euronext: FR0000125346 - ING), announced that it will provide Linio Colombia with advanced payments services, offering its customers an enhanced shopping experience. Linio is a leading online marketplace in Latin America where customers demand smooth and intuitive payment. Ingenico will lead this effort by providing optimized payment solutions to Lino’s customers.
Linio and its shoppers will benefit from Ingenico's extensive experience working for leading ecommerce companies and global partners in more than 170 countries. Ingenico’s solution offers the latest payment methods, security and smooth checkout, boosting conversion rates and customer loyalty.
http://mrem.bernama.com/viewsm.php?idm=34862
Friday, 28 June 2019
S BLOCK IN SOUTHEAST ASIA:EXPLORE VIETNAM, EXPLORING DANANG; DISCOVER BLOCKCHAIN, DISCOVERING S BLOCK
BERN, Switzerland, June 27 (Bernama-BUSINESS WIRE) -- The Digital Economy Application Summit by S BLOCK was successfully held on 26 June 2019 in Danang, Vietnam. This particular summit was hosted by S BLOCK Vietnam Community, co-organized by Magic Kingdom Club in collaboration with Top Market Group Finance and Black Hole Finance media.
Recently, due to the emergence of high-quality projects such as S BLOCK, Vietnam has once again set off a blockchain boom, and Vietnam has reached its highest point in market attention! Recently, according to the reliable source, S BLOCK Vietnam Community held an important economic summit in Vietnam at the end of June. More than 100 industry leaders, 500 well-known economic and blockchain media, over 2,000 industry elites across the world attended the event. The main purpose of the summit is to promote the industry development, to boost Vietnam tourism, and to collaborate and learn more about the blockchain industry. According to relevant news, thanks to the emergence of high-quality projects such as S BLOCK, Vietnam once again took the blockchain boom!
http://mrem.bernama.com/viewsm.php?idm=34859
Recently, due to the emergence of high-quality projects such as S BLOCK, Vietnam has once again set off a blockchain boom, and Vietnam has reached its highest point in market attention! Recently, according to the reliable source, S BLOCK Vietnam Community held an important economic summit in Vietnam at the end of June. More than 100 industry leaders, 500 well-known economic and blockchain media, over 2,000 industry elites across the world attended the event. The main purpose of the summit is to promote the industry development, to boost Vietnam tourism, and to collaborate and learn more about the blockchain industry. According to relevant news, thanks to the emergence of high-quality projects such as S BLOCK, Vietnam once again took the blockchain boom!
http://mrem.bernama.com/viewsm.php?idm=34859
Hotel Royal Classic Osaka accepts online reservation July 1 before Dec 1 opening
KUALA LUMPUR, June 28 (Bernama) -- Japan’s Hotel Royal Classic Osaka will accept online reservations, beginning July 1, although scheduled to open Dec 1.
Operated by Royal Classic Ltd (a subsidiary of Bellco Co Ltd), the hotel was designed by globally celebrated Japanese architect, Kengo Kuma, and incorporates the facade of the former Osaka Shin-Kabukiza theatre.
The opening of the hotel marks the birth of a striking new landmark for the central Osaka Minami Area, according to a statement.
With 150 luxury guest rooms and suites, Hotel Royal Classic Osaka offers a choice of restaurants, function rooms and wedding facilities. An ideal setting for a host of business, bridal and sightseeing applications will also be provided.
The hotel strives to honour the history of a location that served as a crucible for distinctive local cultures, bringing fresh value to Osaka Minami and boosting Osaka’s development as an international tourist hub.
-- BERNAMA
SECURE-24, AN NTT COMMUNICATIONS COMPANY, TO ACQUIRE SYMMETRY, LEADING SAP MANAGED SERVICE PROVIDER IN THE U.S.
TOKYO, June 26 (Bernama-BUSINESS WIRE) -- NTT Communications Corporation (NTT Com), the ICT solutions and international communications business within the NTT Group (TOKYO:9432), and Symmetry Holding Inc. (Symmetry), a U.S.-based leading provider of SAP managed services, announced today that Secure-24 Intermediate Holdings, Inc. (Secure-24), wholly owned subsidiary of NTT Com, entered into a definitive agreement on June 26 (Japan Standard Time), pursuant to which Secure-24 will wholly acquire Symmetry.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190625006084/en/
Managed services are one of the key capabilities NTT Com is strengthening to support its clients’ digital transformations as a DX Enabler™. Secure-24 has been playing key roles for delivering such capabilities especially in the U.S. market. Symmetry possesses extensive expertise in SAP managed services, which it delivers to large enterprise clients in diverse industries including consumer products, life sciences, manufacturing and high-tech in the U.S., the world’s largest market for managed services. Symmetry also offers migration and operations services for SAP S/4 HANA, a flexible, high-speed platform, which is expected to be widely deployed.
http://mrem.bernama.com/viewsm.php?idm=34843
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190625006084/en/
Managed services are one of the key capabilities NTT Com is strengthening to support its clients’ digital transformations as a DX Enabler™. Secure-24 has been playing key roles for delivering such capabilities especially in the U.S. market. Symmetry possesses extensive expertise in SAP managed services, which it delivers to large enterprise clients in diverse industries including consumer products, life sciences, manufacturing and high-tech in the U.S., the world’s largest market for managed services. Symmetry also offers migration and operations services for SAP S/4 HANA, a flexible, high-speed platform, which is expected to be widely deployed.
http://mrem.bernama.com/viewsm.php?idm=34843
WEX PROVIDING SERVICES TO JAPANESE TRAVEL GROUP TIME DESIGN
SINGAPORE, June 26 (Bernama-BUSINESS WIRE) -- WEX Inc. (NYSE: WEX), a leading financial technology service provider, has expanded its commercial footprint globally with the signing in Singapore of Japanese travel company Time Design.
Time Design provides a white-labelled technology booking platform that enables hotels, airlines and online travel agents (OTAs) to sell travel packages on their own websites.
http://mrem.bernama.com/viewsm.php?idm=34836
Time Design provides a white-labelled technology booking platform that enables hotels, airlines and online travel agents (OTAs) to sell travel packages on their own websites.
http://mrem.bernama.com/viewsm.php?idm=34836
Japan, China companies to produce in-wheel motors for electric vehicles
KUALA LUMPUR, June 27 (Bernama) -- Japan’s Shanghai e-Gle New Energy Automotive Co Ltd and China’s Xiangyang CRRC Electric Machinery Co Ltd (a subsidiary of CRRC Group) have partnered to provide advanced power solutions for the new-energy automobile industry.
The partnership which was announced in ZhuZhou, Hunan Province, China recently will initially begin with the project of producing and selling in-wheel motors to automakers by both companies.
Both companies will start to produce in-wheel motors by 2020 and go into full operation, a year later.
The in-wheel motor system is based on the technology to equip each driving wheel with a motor inside and directly control the body of a vehicle and e-Gle has state-of-the-art technology for the system.
China has already become the world’s largest electric vehicle market, as it has been actively promoting the vehicles with subsidies for car makers and consumers, among other policy measures.
Xiangyang CRRC Electric Machinery is the world’s largest railway car manufacturer based in Hunan, China.
Shanghai e-Gle New Energy Automotive Co Ltd is a subsidiary of e-Gle Co Ltd, based in Kawasaki, Kanagawa Prefecture, Japan.
-- BERNAMA
The partnership which was announced in ZhuZhou, Hunan Province, China recently will initially begin with the project of producing and selling in-wheel motors to automakers by both companies.
Both companies will start to produce in-wheel motors by 2020 and go into full operation, a year later.
The in-wheel motor system is based on the technology to equip each driving wheel with a motor inside and directly control the body of a vehicle and e-Gle has state-of-the-art technology for the system.
China has already become the world’s largest electric vehicle market, as it has been actively promoting the vehicles with subsidies for car makers and consumers, among other policy measures.
Xiangyang CRRC Electric Machinery is the world’s largest railway car manufacturer based in Hunan, China.
Shanghai e-Gle New Energy Automotive Co Ltd is a subsidiary of e-Gle Co Ltd, based in Kawasaki, Kanagawa Prefecture, Japan.
-- BERNAMA
REVIVAL IN CORAL AND PEARL JEWELRY AMONG TOP TRENDS FOR 2019
BANGKOK, June 25 (Bernama) -- Pearls with a contemporary twist, playful coral, and innovative new materials and approaches to metals, are top global jewelry design trends for 2019-20 and will be on show at the 64th edition of the Bangkok Gems & Jewelry Fair, which runs from 10-14 September, 2019.
The September Bangkok fair will showcase the hottest trends at the Innovation and Design Zone (IDZ), presenting the most innovative and cutting-edge design products from Thai entrepreneurs.
This is a project of Thailand’s Department of International Trade Promotion (DITP), Ministry of Commerce to support talented designers and business people in the international market place.
“Emerging Thai designers, entrepreneurs and manufacturers, are aware of global trends in jewellery design, and each of the designers or entrepreneurs will adapt those trends to their pieces,” said Kornkamol Anekamai, director of the Thai Trade Center (TTC) in Milan.
“And for brands it’s important to know about the trends and to keep their brand identity. Thus for Thai products you can find pieces that vary in terms of trends and you can find very unique pieces.”
The September Bangkok fair will showcase the hottest trends at the Innovation and Design Zone (IDZ), presenting the most innovative and cutting-edge design products from Thai entrepreneurs.
This is a project of Thailand’s Department of International Trade Promotion (DITP), Ministry of Commerce to support talented designers and business people in the international market place.
“Emerging Thai designers, entrepreneurs and manufacturers, are aware of global trends in jewellery design, and each of the designers or entrepreneurs will adapt those trends to their pieces,” said Kornkamol Anekamai, director of the Thai Trade Center (TTC) in Milan.
“And for brands it’s important to know about the trends and to keep their brand identity. Thus for Thai products you can find pieces that vary in terms of trends and you can find very unique pieces.”
Leading European designers and industry leaders say the high quality of Thai jewelry craftsmanship reinforces their brands and strengthens their position in European markets.
“Our Thai manufacturers are our main supplier. They are very good at selecting the best quality stones and at working on intricate designs and re-cut stones,” says Paris-based designer Lydia Courteille, who has a boutique on the Rue Saint-Honore in central Paris, near the famous Place Vendome high jewellery quarter.
“They respect us in terms of what we ask for, and always try to do their best from an artistic point of view,” Lydia explained.
“Whenever we open the delivery parcel, we fall in love with what they (Thai craftspeople) have completed.”
Having established his eponymous luxury jewelry brand, celebrated Roman designer Alessio Boschi chose to settle in Bangkok, he said not only unparalleled access to talented jewelry artisans, but also for sourcing a wide variety of gemstones as his greatest passion.
Paola De Luca, a respected Italy-based jewellery analyst and forecaster, said: “Thailand's heritage for craftsmanship will appeal to European markets where there is strong demand for superbly made silver gold and color gem-set jewelry among the new wave of consumers."
“Our Thai manufacturers are our main supplier. They are very good at selecting the best quality stones and at working on intricate designs and re-cut stones,” says Paris-based designer Lydia Courteille, who has a boutique on the Rue Saint-Honore in central Paris, near the famous Place Vendome high jewellery quarter.
“They respect us in terms of what we ask for, and always try to do their best from an artistic point of view,” Lydia explained.
“Whenever we open the delivery parcel, we fall in love with what they (Thai craftspeople) have completed.”
Having established his eponymous luxury jewelry brand, celebrated Roman designer Alessio Boschi chose to settle in Bangkok, he said not only unparalleled access to talented jewelry artisans, but also for sourcing a wide variety of gemstones as his greatest passion.
Paola De Luca, a respected Italy-based jewellery analyst and forecaster, said: “Thailand's heritage for craftsmanship will appeal to European markets where there is strong demand for superbly made silver gold and color gem-set jewelry among the new wave of consumers."
The following global design trend themes are highlighted for 2019-20:
Pearls
Since the Sotheby’s sale of a pearl and diamond pendant owned by ill-fated French Queen Marie- Antoinette for a world record price for a pearl of $36 million last November, there has been a strong revival in consumers’ fascination for pearl jewelry.
Some pearl jewelry pieces in Bangkok show incorporated pearl with diamonds or precious stones featuring a blaze of colour.
The newest designs, seen at European trade shows early this year, present futuristic themes, combining pearls with diamond-encrusted stars and galaxies, and reinterpretations of the past, such as Art Deco tassels.
At the VicenzaOro and Baselworld fairs, brands showed off intricately crafted futuristic pieces inspired by stars and galaxies, and jewelry made from golden South Sea drop shaped pearls combined with unusual formations of diamonds, inspired by the stars.
Coral
PANTONE’s color of the year in 2019 is living coral, a nurturing color that appears in our natural surroundings, influencing a profusion of coral jewelry creations.
Playful and lighthearted coral jewelry featured prominently in the European trade shows in the first quarter of the year.
Precious coral from the great ocean depths is seen as sustainable in jewelry production, paving the way for exciting new creations to enter the global market this year.
Asia is a rich source of deep-sea coral and new creations are expected to be on show at the September edition of BGJF.
Pearls
Since the Sotheby’s sale of a pearl and diamond pendant owned by ill-fated French Queen Marie- Antoinette for a world record price for a pearl of $36 million last November, there has been a strong revival in consumers’ fascination for pearl jewelry.
Some pearl jewelry pieces in Bangkok show incorporated pearl with diamonds or precious stones featuring a blaze of colour.
The newest designs, seen at European trade shows early this year, present futuristic themes, combining pearls with diamond-encrusted stars and galaxies, and reinterpretations of the past, such as Art Deco tassels.
At the VicenzaOro and Baselworld fairs, brands showed off intricately crafted futuristic pieces inspired by stars and galaxies, and jewelry made from golden South Sea drop shaped pearls combined with unusual formations of diamonds, inspired by the stars.
Coral
PANTONE’s color of the year in 2019 is living coral, a nurturing color that appears in our natural surroundings, influencing a profusion of coral jewelry creations.
Playful and lighthearted coral jewelry featured prominently in the European trade shows in the first quarter of the year.
Precious coral from the great ocean depths is seen as sustainable in jewelry production, paving the way for exciting new creations to enter the global market this year.
Asia is a rich source of deep-sea coral and new creations are expected to be on show at the September edition of BGJF.
New materials
The latest generation of designers “mix and match” unusual materials, such as ebony and bakelite, synthetic rubber and nautical cord, with traditional precious metals and gemstones.
The latest generation of designers “mix and match” unusual materials, such as ebony and bakelite, synthetic rubber and nautical cord, with traditional precious metals and gemstones.
Some pieces combined an eclectic mix of innovative materials with precious stones, giving a fresh look to necklaces and bangles rich in color.
One necklace featured rings of African ebony amidst natural gemstones, while a bangle predominantly in jade incorporated a standout bakelite sphere.
At Bangkok show, INTHAI brand applies Thai bamboo handicrafts to create accessories jewelry and decoration, PIROON JEWELRY whose jewelry works inspired by Thai sculpture using paper pulp and artistic creativity to render the creative pieces.
METALS INNOVATION
At Vicenza, one high jewelry brand presented 18-carat gold in a range of colors, launching “chocolate brown” gold rings to complement colored gold such as “natural beige” and “apricot orange.”
The spread of gold colors is due to the use of different combinations of alloys.
A U.S. brand, well known for its lockets in 18-carat gold, ventured into steel jewellery, such as a black steel sun, moon and stars 47-inch chain.
Innovation and Design Zone
At the September Bangkok fair, the newest trends will be showcased at the Innovation and Design Zone (IDZ), which will be divided into two zones.
Zone 1 will feature a Special Exhibition: Innovation and Design Showcase, presenting more than 40 innovation and design products in six groups – Fine Jewelry, Form & Technique, Material, Research, Technology & Tools, and student projects from leading Thai universities.
Zone 2 will be an Innovation and Design Bazaar in which around 12 brands will showcase their innovative products.
The 64th Bangkok Gems & Jewelry Fair will be held from September 10 to 14 , 2 0 1 9 at Challenger Halls 1 -3 , IMPACT Muang Thong Thani. For more information, please visit www.bkkgems.com or dial DITP Call Center 1169.
Bangkok Gems & Jewelry Fair (BGJF) is one of the world’s most renowned and longest-celebrated gems and jewelry trade fair in the industry. Organized on a biannual basis by Thailand’s Department of International Trade Promotion (DITP), Ministry of Commerce, in February and September, the Bangkok Gems & Jewelry Fair is regarded as a significant trading arena where all key players in the global gems and jewelry business can achieve their purposes of sourcing, trading, networking.
Source: Royal Thai Embassy
One necklace featured rings of African ebony amidst natural gemstones, while a bangle predominantly in jade incorporated a standout bakelite sphere.
At Bangkok show, INTHAI brand applies Thai bamboo handicrafts to create accessories jewelry and decoration, PIROON JEWELRY whose jewelry works inspired by Thai sculpture using paper pulp and artistic creativity to render the creative pieces.
METALS INNOVATION
At Vicenza, one high jewelry brand presented 18-carat gold in a range of colors, launching “chocolate brown” gold rings to complement colored gold such as “natural beige” and “apricot orange.”
The spread of gold colors is due to the use of different combinations of alloys.
A U.S. brand, well known for its lockets in 18-carat gold, ventured into steel jewellery, such as a black steel sun, moon and stars 47-inch chain.
Innovation and Design Zone
At the September Bangkok fair, the newest trends will be showcased at the Innovation and Design Zone (IDZ), which will be divided into two zones.
Zone 1 will feature a Special Exhibition: Innovation and Design Showcase, presenting more than 40 innovation and design products in six groups – Fine Jewelry, Form & Technique, Material, Research, Technology & Tools, and student projects from leading Thai universities.
Zone 2 will be an Innovation and Design Bazaar in which around 12 brands will showcase their innovative products.
The 64th Bangkok Gems & Jewelry Fair will be held from September 10 to 14 , 2 0 1 9 at Challenger Halls 1 -3 , IMPACT Muang Thong Thani. For more information, please visit www.bkkgems.com or dial DITP Call Center 1169.
Bangkok Gems & Jewelry Fair (BGJF) is one of the world’s most renowned and longest-celebrated gems and jewelry trade fair in the industry. Organized on a biannual basis by Thailand’s Department of International Trade Promotion (DITP), Ministry of Commerce, in February and September, the Bangkok Gems & Jewelry Fair is regarded as a significant trading arena where all key players in the global gems and jewelry business can achieve their purposes of sourcing, trading, networking.
Source: Royal Thai Embassy
Thursday, 27 June 2019
METRONOME DELIVERS WORLD'S FIRST CROSS-BLOCKCHAIN TRANSFER CAPABILITY
Chainhop Feature Advances the Vision of a Built-to-Last Cryptocurrency
CHICAGO, June 27 (Bernama-BUSINESS WIRE) -- Fulfilling the promise of providing the world’s first two-way, cross-blockchain cryptocurrency, Metronome ($MET) today announced that it has initiated a first-of-its-kind transfer of MET tokens from one blockchain to another – Ethereum ($ETH) to Ethereum Classic ($ETC) – and back. This chainhop feature, available to all Metronome users, represents a significant step in how the financial and technology industries could approach cryptocurrencies as an enduring asset class.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190626005869/en/
Conventionally, cryptocurrencies are tied to their native blockchain, or the publicly maintained ledger that records their users’ transactions. This is similar to having someone’s money anchored to their bank’s bookkeeping system, forcing them to exchange their “Bank ‘A’ dollars” for “Bank ‘B’ dollars” should they want to switch banks for any reason, such as high fees, poor service, or disagreements over governance. Further, the cryptocurrency-to-native-blockchain relationship potentially jeopardizes the safety of one’s digital assets, since it is wholly dependent on the stability of the community that maintains that currency and its blockchain.
With the introduction of Metronome’s chainhop capability, the Metronome team showed that it is possible to maintain your holdings in a cryptocurrency and choose the blockchain ledger that most suits one’s requirements for stability and governance.
Jeff Garzik, the principal architect of Metronome and one of Bitcoin’s original contributors, offered additional context and detail in a Medium post:
“Decentralization is an article of faith within the blockchain industry and drives a lot of what we all do. That said, one species of centralization that our industry has become comfortable with is the notion that a digital asset must be forever tied to its blockchain ledger. … Metronome expands how we think of decentralization — the elimination of chain permanence.”
This cross-chain capability is available via the Metronome desktop wallet (Windows, MacOS, and Linux), as well as the mobile wallets for iOS and Android. For developers, all components are available on GitHub.
The Metronome team continues to explore new chainhops and has made significant headway for launch on other networks, such as QTUM and RSK, and conducting further research on EOS and Cardano. This expands user choice and the overall potential for the currency.
About Metronome
Launched in 2018, Metronome is a wholly autonomous cryptocurrency built for:
● Usability: Metronome uniquely supports all currency use-cases – store of value, unit of account, and payment mechanism – for both humans and machines;
● Fairness: Nobody holds special privileges or access in the Metronome ecosystem, with all opportunities to purchase Metronome made available to the public; and
● Endurance: Metronome was designed to be the first cryptocurrency to move across blockchains, offering a unique level of digital asset protection.
Media and Community Resources
Readers can explore the following resources to learn more about Metronome:
● Metronome meetup kit
● YouTube demonstration of first chainhop
● Telegram
● Medium
● Twitter
● GitHub
The Metronome team strongly encourages all users to review the Owner’s Manual before purchasing or using MET. The Owner’s Manual is available in English, Chinese (Simplified), Japanese, Korean, and Russian.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190626005869/en/
Contact
Contact
Dariusz R. Jakubowski
Community Advocate
dariusz@metronome.io
https://metronome.io/
Source : Metronome
--BERNAMA
CHICAGO, June 27 (Bernama-BUSINESS WIRE) -- Fulfilling the promise of providing the world’s first two-way, cross-blockchain cryptocurrency, Metronome ($MET) today announced that it has initiated a first-of-its-kind transfer of MET tokens from one blockchain to another – Ethereum ($ETH) to Ethereum Classic ($ETC) – and back. This chainhop feature, available to all Metronome users, represents a significant step in how the financial and technology industries could approach cryptocurrencies as an enduring asset class.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190626005869/en/
Conventionally, cryptocurrencies are tied to their native blockchain, or the publicly maintained ledger that records their users’ transactions. This is similar to having someone’s money anchored to their bank’s bookkeeping system, forcing them to exchange their “Bank ‘A’ dollars” for “Bank ‘B’ dollars” should they want to switch banks for any reason, such as high fees, poor service, or disagreements over governance. Further, the cryptocurrency-to-native-blockchain relationship potentially jeopardizes the safety of one’s digital assets, since it is wholly dependent on the stability of the community that maintains that currency and its blockchain.
With the introduction of Metronome’s chainhop capability, the Metronome team showed that it is possible to maintain your holdings in a cryptocurrency and choose the blockchain ledger that most suits one’s requirements for stability and governance.
Jeff Garzik, the principal architect of Metronome and one of Bitcoin’s original contributors, offered additional context and detail in a Medium post:
“Decentralization is an article of faith within the blockchain industry and drives a lot of what we all do. That said, one species of centralization that our industry has become comfortable with is the notion that a digital asset must be forever tied to its blockchain ledger. … Metronome expands how we think of decentralization — the elimination of chain permanence.”
This cross-chain capability is available via the Metronome desktop wallet (Windows, MacOS, and Linux), as well as the mobile wallets for iOS and Android. For developers, all components are available on GitHub.
The Metronome team continues to explore new chainhops and has made significant headway for launch on other networks, such as QTUM and RSK, and conducting further research on EOS and Cardano. This expands user choice and the overall potential for the currency.
About Metronome
Launched in 2018, Metronome is a wholly autonomous cryptocurrency built for:
● Usability: Metronome uniquely supports all currency use-cases – store of value, unit of account, and payment mechanism – for both humans and machines;
● Fairness: Nobody holds special privileges or access in the Metronome ecosystem, with all opportunities to purchase Metronome made available to the public; and
● Endurance: Metronome was designed to be the first cryptocurrency to move across blockchains, offering a unique level of digital asset protection.
Media and Community Resources
Readers can explore the following resources to learn more about Metronome:
● Metronome meetup kit
● YouTube demonstration of first chainhop
● Telegram
● Medium
● GitHub
The Metronome team strongly encourages all users to review the Owner’s Manual before purchasing or using MET. The Owner’s Manual is available in English, Chinese (Simplified), Japanese, Korean, and Russian.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190626005869/en/
Contact
Contact
Dariusz R. Jakubowski
Community Advocate
dariusz@metronome.io
https://metronome.io/
Source : Metronome
--BERNAMA
KOINWORKS, INDONESIA'S LARGEST P2P LENDING PLATFORM, RAISES AN OVERSUBSCRIBED S$16.5 MILLION SERIES B
JAKARTA, Indonesia, June 25 (Bernama-GLOBE NEWSWIRE) -- KoinWorks, Indonesia’s largest peer-to-peer (P2P) lending platform registered and supervised by OJK, today announced its Series B fundraise of S$16.5 million (IDR 170 billion). The oversubscribed round was co-led by EV Growth and Quona Capital, with participation from existing investors. The new funding will be used to expand the KoinWorks team and partnerships, and further develop systems and technology to provide financial inclusion throughout Indonesia with its popular one platform.
KoinWorks was established in 2016 by co-founders Benedicto Haryono and Willy Arifin. The company brings together borrowers and lenders online through a single platform that provides access to financial services for SMEs who have historically been un- or underbanked by traditional financial institutions. Leveraging machine learning, KoinWorks enables borrowers to access low interest loans while funders receive better returns. Available products include business financing and invoice financing.
http://mrem.bernama.com/viewsm.php?idm=34828
KoinWorks was established in 2016 by co-founders Benedicto Haryono and Willy Arifin. The company brings together borrowers and lenders online through a single platform that provides access to financial services for SMEs who have historically been un- or underbanked by traditional financial institutions. Leveraging machine learning, KoinWorks enables borrowers to access low interest loans while funders receive better returns. Available products include business financing and invoice financing.
http://mrem.bernama.com/viewsm.php?idm=34828
Vista Global launches world´s first private aviation marketplace
KUALA LUMPUR, June 27 (Bernama) -- Vista Global Holding has launched XO, the first global digital marketplace for private aviation.
In a statement, the private aviation group founded by Thomas Flohr said the marketplace which was powered by JetSmarter technology, marks the beginning of a new world for all private aviation customers.
Built by combining the trusted operational and customer-centric expertise of XOJET with the speed and convenience of technology originally developed by JetSmarter, the new brand will provide elevated services for On Demand private jet travel.
The launch of XO demonstrates the speed of change and comprehensive range of solutions that Vista Global brings to the business aviation market.
As demand moves towards digital solution, customers can instantly request a flight or book a seat on the XO app or online, with access to thousands of private jets across all categories, from light, midsize, super-midsize and long-range aircraft.
XO Members can also benefit from preferential pricing and guaranteed access and receive 24/7 assistance from XO’s Aviation Advisors.
For more information, visit flyXO.com
-- BERNAMA
-- BERNAMA
HYTERA EMPHASISES ITSELF AS PROFESSIONAL AND PRIVATE WIRELESS COMMUNICATIONS SOLUTION SUPPLIER AT CCW 2019
KUALA LUMPUR, Malaysia, June 24 (Bernama-BUSINESS WIRE) -- After connecting with vertical customers for over 20 years worldwide, Hytera Communications Corporation Limited realized that only turnkey solutions could satisfy them rather than any single device.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190623005022/en/
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190623005022/en/
The company has now emphasised itself as a global provider of professional and private wireless communications solutions to meet global customers’ demands by enriching product portfolios by leveraging narrowband technologies across multiple standards, broadband and new technologies like big data, AI and Internet of Things (IoT), and expanding its global partnership with business stakeholders to consolidate a promising ecosystem.
Wednesday, 26 June 2019
PHUNWARE OFFERS PHUN UTILITY TOKEN GLOBALLY
AUSTIN, Texas, June 26 (Bernama-BUSINESS WIRE) -- Phunware, Inc. (NASDAQ: PHUN) (the “Company”), a fully-integrated enterprise cloud platform for mobile that provides products, solutions, data and services for brands worldwide, announced that Phun utility tokens are now available for purchase in international markets.
“Phun is a new utility token that enables the international community to participate in our blockchain-enabled data exchange and mobile loyalty ecosystem as we drive towards mainstream global adoption and future exchange listings,” said Randall Crowder, Chief Operating Officer of Phunware.
Phunware is an Austin, Texas, headquartered Company with 10 years of success working with the world’s largest organizations. Whether it is enabling immersive gaming and movie experiences for Paramount Pictures International, powering Juniper, Cisco or HP Aruba hardware for app-enabled location services or integrating Electronic Health Records (EHRs) like Epic or Cerner for patient experiences in healthcare, Phunware’s Multiscreen as a Service (MaaS) offerings have been helping Global 1000 companies standardize and optimize their engagement, management and monetization initiatives for iOS and Android devices and audiences across hundreds of thousands of app transactions per second worldwide.
“Our MaaS platform reaches over 1 billion unique devices per month and processes an average of over 4 billion events per day worldwide,” said Alan S. Knitowski, Co-Founder and Chief Executive Officer of Phunware. “Prior to going public at the end of last year, our major strategic investors included Cisco Systems, Samsung, WWE and PLDT, while our mobile solution set addressed the software, data and app needs of organizations as far ranging as the NFL, NASCAR and the Olympic Games in sports to their equivalent peers in verticals including retail, real estate, healthcare, technology, aviation and hospitality.”
To comply with the current regulatory landscape, Phunware recently launched its dual token structure. While Phun is a utility token that enables consumers to monetize their digital activity as they engage in profitable behavior with brands, PhunCoin remains a compliant security token that enables consumers to monetize their digital identity and offers token holders a PhunCoin dividend.
Given the current regulatory environment, Phun will initially only be available outside the United States and Canada. Investors outside the United States and Canada can purchase Phun by registering on https://buy.phuntoken.com/.
For more information on Phun, visit https://www.phuntoken.com/ or email phun@phunware.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190625006051/en/
Contact
PR & Media Inquiries:
Brent Brightwell
bbrightwell@phunware.com
T: (512) 693-4199 x6604
Investor Relations:
Phunware, Inc.
investorrelations@phunware.com
T: (512) 693-4199
Source : Phunware, Inc.
--BERNAMA
“Phun is a new utility token that enables the international community to participate in our blockchain-enabled data exchange and mobile loyalty ecosystem as we drive towards mainstream global adoption and future exchange listings,” said Randall Crowder, Chief Operating Officer of Phunware.
Phunware is an Austin, Texas, headquartered Company with 10 years of success working with the world’s largest organizations. Whether it is enabling immersive gaming and movie experiences for Paramount Pictures International, powering Juniper, Cisco or HP Aruba hardware for app-enabled location services or integrating Electronic Health Records (EHRs) like Epic or Cerner for patient experiences in healthcare, Phunware’s Multiscreen as a Service (MaaS) offerings have been helping Global 1000 companies standardize and optimize their engagement, management and monetization initiatives for iOS and Android devices and audiences across hundreds of thousands of app transactions per second worldwide.
“Our MaaS platform reaches over 1 billion unique devices per month and processes an average of over 4 billion events per day worldwide,” said Alan S. Knitowski, Co-Founder and Chief Executive Officer of Phunware. “Prior to going public at the end of last year, our major strategic investors included Cisco Systems, Samsung, WWE and PLDT, while our mobile solution set addressed the software, data and app needs of organizations as far ranging as the NFL, NASCAR and the Olympic Games in sports to their equivalent peers in verticals including retail, real estate, healthcare, technology, aviation and hospitality.”
To comply with the current regulatory landscape, Phunware recently launched its dual token structure. While Phun is a utility token that enables consumers to monetize their digital activity as they engage in profitable behavior with brands, PhunCoin remains a compliant security token that enables consumers to monetize their digital identity and offers token holders a PhunCoin dividend.
Given the current regulatory environment, Phun will initially only be available outside the United States and Canada. Investors outside the United States and Canada can purchase Phun by registering on https://buy.phuntoken.com/.
For more information on Phun, visit https://www.phuntoken.com/ or email phun@phunware.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190625006051/en/
Contact
PR & Media Inquiries:
Brent Brightwell
bbrightwell@phunware.com
T: (512) 693-4199 x6604
Investor Relations:
Phunware, Inc.
investorrelations@phunware.com
T: (512) 693-4199
Source : Phunware, Inc.
--BERNAMA
SIX SINGAPOREAN CHARTERED ACCOUNTANTS RECEIVE PRESTIGIOUS FELLOWSHIPS
SYDNEY, June 24, 2019 /Medianet International-AsiaNet/--
Six Singaporean Chartered Accountants have tonight received Fellowships, the highest recognition in the accounting profession.
Chartered Accountants Australia and New Zealand President Stephen Walker presented the awards tonight at the annual President's Dinner in Singapore as eighteen Chartered Accountants were recognised for their achievements.
http://mrem.bernama.com/viewsm.php?idm=34816
Six Singaporean Chartered Accountants have tonight received Fellowships, the highest recognition in the accounting profession.
Chartered Accountants Australia and New Zealand President Stephen Walker presented the awards tonight at the annual President's Dinner in Singapore as eighteen Chartered Accountants were recognised for their achievements.
http://mrem.bernama.com/viewsm.php?idm=34816
HYTERA LAUNCHES NEW MULTI-MODE ADVANCED RADIO
KUALA LUMPUR, Malaysia, June 24 (Bernama-BUSINESS WIRE) -- On June 19th, Hytera launched a new multi-mode advanced radio at CCW 2019 in Malaysia, which will bring the latest professional radio communication technology to customers from both private and public sectors.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190621005184/en/
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190621005184/en/
As one of the most famous PMR exhibitions in the world, CCW attracted much attention and participation of the top professional users, operators, developers and manufacturers from all over the world. The innovated broadband and narrowband hybrid was the hotspot during this exhibition. This time Hytera presented the full range of the multi-mode advanced radios which were designed to meet the different needs.
S BLOCK has footprint in over 30 countries
KUALA LUMPUR, June 26 (Bernama) -- S BLOCK, co-host of 2019 WBF Singapore Technology Conference recently unveiled itself, announcing a mission to unleash digital assets.
The conference drew great attention from across the global blockchain industry, according to a statement.
The S BLOCK Global Foundation president, identified only as Ivan, was invited to deliver a keynote address, whereby, S BLOCK was officially launched in more than 30 countries, together with the signing of strategic agreement with DUSD and WBFex, to accelerate its (S BLOCK’s) development.
S BLOCK will continue to develop digital finance businesses in the world, and finally form a complete global digital financial ecosystem to further improve the ecosystem layout and enhance competitiveness of the products.
The conference was attended by numerous industry elites and blockchain enthusiasts from Switzerland, Germany, France, Russia, Japan, Korea, Brazil, Australia, Argentina and Canada.
-- BERNAMA
'Mover and shaker' Stuart Fisher helms Kinetica Asia Pacific
KUALA LUMPUR, June 26 (Bernama) -- Kinetica, the Active Analytics Platform for the Extreme Data Economy has appointed Stuart Fisher as president, Asia Pacific, reflecting continued sales growth and significant momentum in the region.
His hiring follows Kinetica’s several recent outstanding accomplishments, including the appointment of Elizabeth McGlauflin as chief customer success officer, and adoption by major Asia-Pacific brands from Japan to Australia, including Softbank.
“We are deeply fortunate to have the opportunity to bring on a high-calibre leader like Stuart to guide the massive, transformative journeys of our customers, with broad experience and skills to expand the business in Asia Pacific,” said Kinetica chief executive officer, Paul Appleby.
Previously, Fisher was senior vice-president at Deep Instinct, regional vice-president and managing director (Asia Pacific) at Sophos, and regional vice-president at Sybase, among others.
Kinetica Active Analytics brings together, all key elements of dynamic analytics in a unified platform, including historical data analytics, streaming data analytics, location intelligence and artificial intelligence.
Tuesday, 25 June 2019
Unveiled: Polyplastics DURACON POM grades for automotive fuel system components
KUALA LUMPUR, June 25 (Bernama) -- The Polyplastics Group, a global leader in the development and production of engineering thermoplastics has developed new DURACON polyoxymethylene (POM) grades for the production of injection-molded automotive fuel system components.
The grades deliver high flow, high rigidity and design freedom of the system and its new materials complement Polyplastics' flagship DURACON POM portfolio which is already widely used, according to a statement.
The company has commercially launched DURACON H140-54C, a high-flow/high-rigidity grade with a melt flow rate of around 14. This material suits a wide range of molding conditions and is used in Europe.
It also announced a developmental POM grade which provides exceptional acid resistance. Historically, one of POM's limitations has been its vulnerability to strong acids, but this new material provides significant improvements.
Polyplastics has also developed an electrically conductive grade for use in components that surround fuel as a measure against static electricity whereby, it can impart conductivity while also maintaining POM's key performance attributes, including flowability and toughness.
AXIOMSL PARTNERS WITH REFINITIV FOR GLOBAL SHAREHOLDING DISCLOSURES DATA ENRICHMENT
NEW YORK & LONDON & SINGAPORE & MEDELLIN, June 25 (Bernama-BUSINESS WIRE) --AxiomSL, the leading provider of regulatory reporting and risk management solutions, today announces that it has entered into a partnership with Refinitiv, one of the world’s largest providers of financial markets data and infrastructure. Combining AxiomSL’s robust Global Shareholding Disclosures (GSD) solution with Refinitiv’s reference data enables Financial Institutions (FIs) to automatically enrich their clients’ positions while managing regulatory obligations across multiple jurisdictions.
As financial markets become increasingly more complex and global in nature, FIs face three main challenges:
As financial markets become increasingly more complex and global in nature, FIs face three main challenges:
- Keeping up with regulatory rules and reporting template requirements across 100 countries
- Accessing reliable market data to ensure that position percentage calculations are accurate
- Automating the process for GSD reporting to meet daily monitoring requirements
The combination of Refinitiv's comprehensive reference data, including issuer and class level shares, voting rights, and takeover panel data, and AxiomSL’s ControllerView® platform that provides monitoring, automation and transparency enables market participants to understand data and reporting issues to successfully comply with shareholding disclosure requirements, globally.
Refinitiv’s GSD data comes pre-configured for compatibility on the AxiomSL platform to deliver full traceability throughout the monitoring process. This collaborative approach reduces the burden on clients to source and integrate market data while enhancing the automation of the entire end-to-end monitoring process.
John Mason, Head of Pricing and Reference Data, Refinitiv, commented: “Asset managers face a significant challenge in understanding local rules around shareholder disclosures and calculating their own holdings given the complexities around voting rights and share classes. This partnership provides a simple solution by combining AxiomSL’s state of the art technology with Refinitiv’s comprehensive global data, enabling asset managers to quickly and easily assess their positions in different instruments.”
Ed Royan, General Manager, AxiomSL EMEA, commented: “We are pleased to partner with Refinitiv, one of the world’s largest providers of financial markets data and infrastructure, in addressing the challenges of data transparency requirements set out by regulatory authorities across the globe when rules differs from country to country. These challenges range from sourcing high quality market data to addressing jurisdictional nuances to remain aligned with disclosure rules. This partnership unlocks many benefits from streamlining and automating complex rules to seamlessly ingesting and aggregating disparate data resulting in a rapid go-live process.”
http://mrem.bernama.com/viewsm.php?idm=34829
TERNS PHARMACEUTICALS ANNOUNCES EXCLUSIVE LICENSING AND COLLABORATION AGREEMENT WITH GENFIT TO DEVELOP AND COMMERCIALIZE ELAFIBRANOR IN THE GREATER CHINA REGION
-GENFIT partnership expands Terns’ portfolio, adding a Phase 3 product with a complementary mechanism of action well-suited to combinations with Terns’ NASH assets-
FOSTER CITY, Calif. & SHANGHAI, June 25 (Bernama-BUSINESS WIRE) --Terns Pharmaceuticals, Inc. today announced an exclusive licensing and collaboration agreement with GENFIT (GNFT), a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver-related diseases. Under the terms of the agreement, Terns acquires the exclusive right to develop, register, and market elafibranor for the treatment of non-alcoholic steatohepatitis (NASH) and primary biliary cholangitis (PBC) in Greater China (mainland China, Hong Kong, Macau, and Taiwan). GENFIT will receive a $35 million upfront payment and will be eligible to receive up to $193 million in subsequent payments, based on achieving clinical, regulatory, and commercial milestones. The two companies will also collaborate on research and development moving forward in NASH and PBC. These research and development efforts include potential combinations of elafibranor, a dual peroxisome proliferator-activated alpha/delta (PPAR α/δ ) agonist, with Terns’ development candidates, including TERN-101, a farnesoid X receptor (FXR) agonist, TERN-201, a semicarbazide-sensitive amine oxidase (SSAO) inhibitor, and their thyroid hormone receptor (THR) β-selective agonist and apoptosis signal-regulating kinase 1 (ASK1) inhibitor programs.
“Terns is committed to bringing new, innovative therapies for the treatment of liver disease to China and other global markets. Our partnership with GENFIT is a natural next step for us as a company,” said Weidong Zhong, Ph.D., Chief Executive Officer of Terns. “We believe combination therapy will rapidly become the standard of care for NASH treatment, and our strategy is based on this conviction. Elafibranor is a late-stage compound with a mechanism of action synergistic with those in our own pipeline, making it a perfect fit for our strategy to advance combination therapies for chronic liver disease. We’re excited to add elafibranor to our portfolio, to expand our focus on liver disease to include PBC, and to gain a strong partner in GENFIT, a company that shares our focus on developing innovative treatments for liver disease.”
“The team at Terns has an extensive track record in drug development combined with the infrastructure to successfully develop, register and commercialize new therapies in Asia,” said Pascal Prigent, Executive Vice President of Marketing and Commercial Development at GENFIT. “We have great confidence in the company and its management team as we work to bring elafibranor to patients in Greater China and to collaborate on future R&D efforts and combination strategies.”
The licensing and collaboration agreement with GENFIT follows the 2018 announcement that Terns acquired the global, exclusive rights to develop and commercialize three NASH assets from Eli Lilly and Company. Collectively, these agreements demonstrate Terns' commitment to enhancing its pipeline through partnerships with regional and global companies, in addition to internal discovery efforts, to accelerate effective combination therapies for patients living with chronic liver disease.
About elafibranor
Elafibranor is GENFIT’s lead pipeline product candidate. Elafibranor is an oral, once-daily, first-in-class drug acting via dual peroxisome proliferator-activated alpha/delta pathways developed to treat, in particular, nonalcoholic steatohepatitis (NASH), for which it has been granted Fast Track Designation. GENFIT believes, based on clinical results to date, that elafibranor has the potential to address multiple facets of NASH, including inflammation, insulin sensitivity, lipid/metabolic profile, and liver markers. Results from a Phase 3 study in patients with NASH is expected in the fourth quarter 2019. Phase 2 clinical trial results have also shown that elafibranor may be an effective treatment for PBC, a severe liver disease. Elafibranor was granted a Breakthrough Therapy Designation for this indication.
About NASH
Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease (NAFLD), which is caused by the accumulation of excess fat in the liver. NASH is associated with chronic liver inflammation and liver cell injury, and it can lead to fibrosis, cirrhosis, and eventually liver cancer or liver failure. Global rates of NAFLD and NASH are increasing rapidly, in tandem with rising rates of obesity. There is currently no approved medication for the treatment of NASH.
About PBC
PBC is a chronic disease in which damage to bile ducts can inhibit the liver’s ability to rid the body of toxins and can lead to scarring of liver tissue known as cirrhosis.
About Terns Pharmaceuticals
Terns Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company that is focused on the discovery and development of medicines for chronic liver disease and cancer. Based in China and the United States, the company is advancing a pipeline of drug candidates for the treatment of non-alcoholic steatohepatitis (NASH) and cancer, across multiple modalities. Terns leverages world class expertise in disease biology, medicinal chemistry, and clinical development in order to bring promising new therapies to patients in China and other global markets.
For more information, visit www.ternspharma.com and www.ternspharma.com.cn
About GENFIT
GENFIT is a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases where there are considerable unmet medical needs, corresponding to a lack of approved treatments. GENFIT is a leader in the field of nuclear receptor-based drug discovery with a rich history and strong scientific heritage spanning almost two decades. Its most advanced drug candidate, elafibranor, is currently being evaluated in a pivotal Phase 3 clinical trial (“RESOLVE-IT”) as a potential treatment for NASH, and GENFIT plans to initiate a Phase 3 clinical trial in PBC later this year following its positive Phase 2 results. As part of GENFIT’s comprehensive approach to clinical management of NASH patients, the company is also developing a new, non-invasive and easy-to-access blood-based in vitro diagnostic test to identify patients with NASH who may be appropriate candidates for drug therapy. With facilities in Lille and Paris, France, and Cambridge, MA, USA, the Company has approximately 160 employees. GENFIT is a public company listed on the Nasdaq Global Select Market and in compartment B of Euronext’s regulated market in Paris (Nasdaq and Euronext: GNFT). www.genfit.com
FORWARD LOOKING STATEMENTS
This press release contains certain forward-looking statements, including those within the meaning of the Private Securities Litigation Reform Act of 1995, with respect to GENFIT, including the potential to and success of commercialization of elafibranor in Greater China and the effect of new regulations in China to accelerate and facilitate drug approvals. The use of certain words, including “believe,” “potential,” “expect” and “will” and similar expressions, is intended to identify forward-looking statements. Although the Company believes its expectations are based on the current expectations and reasonable assumptions of the Company’s management, these forward-looking statements are subject to numerous known and unknown risks and uncertainties, which could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking statements. These risks and uncertainties include, among other things, the uncertainties inherent in research and development, including related to safety, biomarkers, progression of, and results from, its ongoing and planned clinical trials, review and approvals by regulatory authorities of its drug and diagnostic candidates and the Company’s continued ability to raise capital to fund its development, as well as those risks and uncertainties discussed or identified in the Company’s public filings with the French Autorité des marchés financiers (“AMF”), including those listed in Section 4 “Main Risks and Uncertainties” of the Company’s 2018 Registration Document filed with the AMF on February 27, 2019 under n° D.19-0078, which is available on GENFIT’s website (www.genfit.com) and on the website of the AMF (www.amf-france.org) and public filings and reports filed with the U.S. Securities and Exchange Commission (“SEC”), including the Company’s final prospectus dated March 26, 2019, and subsequent filings and reports filed with the AMF or SEC, or otherwise made public, by the Company. In addition, even if the Company’s results, performance, financial condition and liquidity, and the development of the industry in which it operates are consistent with such forward-looking statements, they may not be predictive of results or developments in future periods. These forward-looking statements speak only as of the date of publication of this document. Other than as required by applicable law, the Company does not undertake any obligation to update or revise any forward-looking information or statements, whether as a result of new information, future events or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190624005672/en/
Contact
Terns Pharmaceuticals, Inc.
US Media Contact:
Margaret Robinson
mrobinson@ternspharma.com
+1 (415) 690 0084
China Media Contact:
Yan Wan
ywan@ternspharma.com
+86 186 1196 5371
GENFIT
Investors
Naomi EICHENBAUM – Investor Relations | Tel: +1 (617) 714 5252 | investors@genfit.com
Media
Hélène LAVIN – Press Relations | Tel: +333 2016 4000 | helene.lavin@genfit.com
Source : Terns Pharmaceuticals, Inc.
--BERNAMA
FOSTER CITY, Calif. & SHANGHAI, June 25 (Bernama-BUSINESS WIRE) --Terns Pharmaceuticals, Inc. today announced an exclusive licensing and collaboration agreement with GENFIT (GNFT), a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver-related diseases. Under the terms of the agreement, Terns acquires the exclusive right to develop, register, and market elafibranor for the treatment of non-alcoholic steatohepatitis (NASH) and primary biliary cholangitis (PBC) in Greater China (mainland China, Hong Kong, Macau, and Taiwan). GENFIT will receive a $35 million upfront payment and will be eligible to receive up to $193 million in subsequent payments, based on achieving clinical, regulatory, and commercial milestones. The two companies will also collaborate on research and development moving forward in NASH and PBC. These research and development efforts include potential combinations of elafibranor, a dual peroxisome proliferator-activated alpha/delta (PPAR α/δ ) agonist, with Terns’ development candidates, including TERN-101, a farnesoid X receptor (FXR) agonist, TERN-201, a semicarbazide-sensitive amine oxidase (SSAO) inhibitor, and their thyroid hormone receptor (THR) β-selective agonist and apoptosis signal-regulating kinase 1 (ASK1) inhibitor programs.
“Terns is committed to bringing new, innovative therapies for the treatment of liver disease to China and other global markets. Our partnership with GENFIT is a natural next step for us as a company,” said Weidong Zhong, Ph.D., Chief Executive Officer of Terns. “We believe combination therapy will rapidly become the standard of care for NASH treatment, and our strategy is based on this conviction. Elafibranor is a late-stage compound with a mechanism of action synergistic with those in our own pipeline, making it a perfect fit for our strategy to advance combination therapies for chronic liver disease. We’re excited to add elafibranor to our portfolio, to expand our focus on liver disease to include PBC, and to gain a strong partner in GENFIT, a company that shares our focus on developing innovative treatments for liver disease.”
“The team at Terns has an extensive track record in drug development combined with the infrastructure to successfully develop, register and commercialize new therapies in Asia,” said Pascal Prigent, Executive Vice President of Marketing and Commercial Development at GENFIT. “We have great confidence in the company and its management team as we work to bring elafibranor to patients in Greater China and to collaborate on future R&D efforts and combination strategies.”
The licensing and collaboration agreement with GENFIT follows the 2018 announcement that Terns acquired the global, exclusive rights to develop and commercialize three NASH assets from Eli Lilly and Company. Collectively, these agreements demonstrate Terns' commitment to enhancing its pipeline through partnerships with regional and global companies, in addition to internal discovery efforts, to accelerate effective combination therapies for patients living with chronic liver disease.
About elafibranor
Elafibranor is GENFIT’s lead pipeline product candidate. Elafibranor is an oral, once-daily, first-in-class drug acting via dual peroxisome proliferator-activated alpha/delta pathways developed to treat, in particular, nonalcoholic steatohepatitis (NASH), for which it has been granted Fast Track Designation. GENFIT believes, based on clinical results to date, that elafibranor has the potential to address multiple facets of NASH, including inflammation, insulin sensitivity, lipid/metabolic profile, and liver markers. Results from a Phase 3 study in patients with NASH is expected in the fourth quarter 2019. Phase 2 clinical trial results have also shown that elafibranor may be an effective treatment for PBC, a severe liver disease. Elafibranor was granted a Breakthrough Therapy Designation for this indication.
About NASH
Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease (NAFLD), which is caused by the accumulation of excess fat in the liver. NASH is associated with chronic liver inflammation and liver cell injury, and it can lead to fibrosis, cirrhosis, and eventually liver cancer or liver failure. Global rates of NAFLD and NASH are increasing rapidly, in tandem with rising rates of obesity. There is currently no approved medication for the treatment of NASH.
About PBC
PBC is a chronic disease in which damage to bile ducts can inhibit the liver’s ability to rid the body of toxins and can lead to scarring of liver tissue known as cirrhosis.
About Terns Pharmaceuticals
Terns Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company that is focused on the discovery and development of medicines for chronic liver disease and cancer. Based in China and the United States, the company is advancing a pipeline of drug candidates for the treatment of non-alcoholic steatohepatitis (NASH) and cancer, across multiple modalities. Terns leverages world class expertise in disease biology, medicinal chemistry, and clinical development in order to bring promising new therapies to patients in China and other global markets.
For more information, visit www.ternspharma.com and www.ternspharma.com.cn
About GENFIT
GENFIT is a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases where there are considerable unmet medical needs, corresponding to a lack of approved treatments. GENFIT is a leader in the field of nuclear receptor-based drug discovery with a rich history and strong scientific heritage spanning almost two decades. Its most advanced drug candidate, elafibranor, is currently being evaluated in a pivotal Phase 3 clinical trial (“RESOLVE-IT”) as a potential treatment for NASH, and GENFIT plans to initiate a Phase 3 clinical trial in PBC later this year following its positive Phase 2 results. As part of GENFIT’s comprehensive approach to clinical management of NASH patients, the company is also developing a new, non-invasive and easy-to-access blood-based in vitro diagnostic test to identify patients with NASH who may be appropriate candidates for drug therapy. With facilities in Lille and Paris, France, and Cambridge, MA, USA, the Company has approximately 160 employees. GENFIT is a public company listed on the Nasdaq Global Select Market and in compartment B of Euronext’s regulated market in Paris (Nasdaq and Euronext: GNFT). www.genfit.com
FORWARD LOOKING STATEMENTS
This press release contains certain forward-looking statements, including those within the meaning of the Private Securities Litigation Reform Act of 1995, with respect to GENFIT, including the potential to and success of commercialization of elafibranor in Greater China and the effect of new regulations in China to accelerate and facilitate drug approvals. The use of certain words, including “believe,” “potential,” “expect” and “will” and similar expressions, is intended to identify forward-looking statements. Although the Company believes its expectations are based on the current expectations and reasonable assumptions of the Company’s management, these forward-looking statements are subject to numerous known and unknown risks and uncertainties, which could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking statements. These risks and uncertainties include, among other things, the uncertainties inherent in research and development, including related to safety, biomarkers, progression of, and results from, its ongoing and planned clinical trials, review and approvals by regulatory authorities of its drug and diagnostic candidates and the Company’s continued ability to raise capital to fund its development, as well as those risks and uncertainties discussed or identified in the Company’s public filings with the French Autorité des marchés financiers (“AMF”), including those listed in Section 4 “Main Risks and Uncertainties” of the Company’s 2018 Registration Document filed with the AMF on February 27, 2019 under n° D.19-0078, which is available on GENFIT’s website (www.genfit.com) and on the website of the AMF (www.amf-france.org) and public filings and reports filed with the U.S. Securities and Exchange Commission (“SEC”), including the Company’s final prospectus dated March 26, 2019, and subsequent filings and reports filed with the AMF or SEC, or otherwise made public, by the Company. In addition, even if the Company’s results, performance, financial condition and liquidity, and the development of the industry in which it operates are consistent with such forward-looking statements, they may not be predictive of results or developments in future periods. These forward-looking statements speak only as of the date of publication of this document. Other than as required by applicable law, the Company does not undertake any obligation to update or revise any forward-looking information or statements, whether as a result of new information, future events or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190624005672/en/
Contact
Terns Pharmaceuticals, Inc.
US Media Contact:
Margaret Robinson
mrobinson@ternspharma.com
+1 (415) 690 0084
China Media Contact:
Yan Wan
ywan@ternspharma.com
+86 186 1196 5371
GENFIT
Investors
Naomi EICHENBAUM – Investor Relations | Tel: +1 (617) 714 5252 | investors@genfit.com
Media
Hélène LAVIN – Press Relations | Tel: +333 2016 4000 | helene.lavin@genfit.com
Source : Terns Pharmaceuticals, Inc.
--BERNAMA
Subscribe to:
Posts (Atom)